Poster Abstract Session:
238. Hepatitis A, B, and C
Saturday, October 6, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Global ID, HIV-STD-TB, Investigative ID, Pediatric ID

Hepatitis A Outbreak in Southeast Michigan: No Longer a Third World Disease
Sarah Altamimi, MD; Amit Vahia, M.D., M.P.H.; Helina Misikir, MPH; Marcus Zervos, MD; Katherine C. Reyes, MD, MPH
Hepatitis A in Greece 2009-2017. Time for Setting New Priorities.
Kassiani Mellou, PHD; Anthi Chrysostomou, RN, MSc; Theologia Sideroglou, MPH; Sotirios Tsiodras, MD, MSc, PhD, FIDSA; Theano Georgakopoulou, MD, MSc, MPH, PhD
Disparities in Hepatitis A Virus (HAV) Vaccination Coverage Among Adult Travelers to High-Risk Countries: The Role of Nativity and Race
Navaneeth Narayanan, PharmD, BCPS; Mohamed Elsaid, MPH, ALM, LEED-GA; Rachel NeMoyer, MD; Niti Trivedi, MPH Student; Uroosa Zeb, MPH Student; Vinod Rustgi, MD, MBA
Hepatitis B Care Cascade within the VA Maryland Health Care System
Tyler Lambing, MD; Lydia Tang, MB, BCh; Lauren A. Beste, MD, MS; Anthony Amoroso, MD; Eleanor Wilson, MD, MHS
  • finalposter.pdf (809.2 kB)
  • Effectiveness of a Dual-Test Strategy and Software Modifications for Mitigating & Preventing Hepatitis B Virus (HBV) Exposures in a Dialysis Unit
    Emil Lesho, DO, FACP, FIDSA, FSHEA; John Kevin Hix, MD; Melissa Bronstein, MPA; Shubha Shastry, MD; Margaret Pettis, MPA; Gina Scroggins, MSN; Kelly Vore, PhD; Marvin Grieff, MD
    Effect of Depression, Anxiety, Stigma, and Disclosure on Quality of Life among People Living with Hepatitis B Infection in Dalian, China
    Ge Li, MD; Gongchen Wang, MD; Fang-Chi Hsu, PHD; Xia Pei, B.S.; Bo Zhao, B.S.; Jianzhao Xu, B.S.; Avinash Shetty, MD
    Increased Global Incidence and Altered Demographic Profile of Hepatitis Delta Virus (HDV)
    Melodie Weller, PhD; Elaine Cooke, B.S.; Amir GhaziTabatabaei, B.S.; Chih-Ching Yeh, M.S.; Yue Zhang, PhD
    Antiviral Therapy Use in Hepatitis B-Infected Pregnant Women
    Sarah Schillie, MD, MPH, MBA; Noele Nelson, MD, PhD, MPH; Julie Lazaroff, MPH; Elizabeth Burkhardt, MSPH; Patrick Fineis, BA; Sarah Born, RN; Deborah Hinds, MPH; Alaya Koneru, MPH
    The Hepatitis C Virus Cascade of Care at Stony Brook University Hospital: Risk Factors for Linkage to Care
    Audun Lier, MD, MPH; Kalie Smith, BS; Silvia Bronson, MS; Teresa Khoo, MD; Kerim Odekon, MD; Ruth Abeles, MD, MS; Pruthvi Patel, MD; Gerald Kelly, MD; Mathew Tharakan, MD; Manal Soliman, MD. MBA; Bettina C. Fries, MD, FIDSA; Luis A. Marcos, MD, MPH
    Risk Factors for Hepatitis C in Western Africa: An Observational Study in a STI Clinic
    Eda Akyar, MPH; Nallely Mora, MD, MPH; Amy Luke, PhD; Jennifer Layden, MD, PhD; Richard Phillips, MD; Thomas Agyarko-Poku, MD; Dorcas Owusu, MS; Helena A-Siaw, MS; Ronald Nahass, MD, FIDSA, FSHEA
  • Akyar IDWeek2018 Final.pdf (296.8 kB)
  • Mandatory Infectious Diseases or Hepatology Consult to Improve HCV Linkage to Care in the Inpatient Setting
    Marinela Ingilizova, MD; Dagan Coppock, MD; Zsofia Szep, MD; Kevin D'Mello, MD; Anna Kesaris, Research Assistant; Tiffany Scott, Research Assistant; Taneesa Franks, Research assistant; Edgar Chou, MD; Dong Heun Lee, MD
  • Sherbuk_IDWeek.pdf (560.0 kB)
  • Barriers to HCV Treatment in a Safety-Net Hospital System
    Sabhi Gull, MD; Lisa Quirk, MS, MPH; Jennifer McBryde, PA-C; Nicole Rich, MD; Amit Singal, MD; Mamta K Jain, MD, MPH
    Fibrosis Surveillance by Transient Elastography in Patients with Untreated Hepatitis C Infection
    Oluwatoyin Adeyemi, MD; Kerianne Burke, MPH; Crystal Winston, BA; Sara Markham, BS; Dan Taussig, MPH; Benjamin Go, MD; Greg Huhn, MD
    Discordance between FibroSure and FibroScan results in Hepatitis C and Human Immunodeficiency Virus co-infected patients prior to treatment for Hepatitis C virus infection
    Melissa Tiyouh, MD; Dong Heun Lee, MD; Taneesa Franks, Research assistant; Tiffany Scott, Research Assistant; Anna Kesaris, Research Assistant; Edgar Chou, MD; Dagan Coppock, MD
  • IDSA poster - Melissa.pdf (77.8 kB)
  • An Online Survey of Hepatitis C Testing Attitudes and Practice Habits Among Residents at an Urban Medical Center
    Jason Zucker, MD; Caroline Carnevale, FNP, MPH, AAHIVS; Matthew Scherer, MD; Alwyn Cohall, MD; Magdalena Sobieszczyk, MD, MPH; Peter Gordon, MD; Susan Olender, MD, MS
  • Zucker_HCV_Survey.pdf (885.6 kB)
  • Hepatitis C Testing and Linkage to Care in a Public Health Setting in North Carolina: Addressing Gaps along the Care Continuum
    Arlene Sena, MD, MPH; Candice Givens, MSW; Gwendolyn McKnight, BSPH; Joseph Thayer, BA; Alison Hilton, MPH
    Preliminary screening results outside the 1945-1965 birth cohort: A forgotten population for HCV?
    Daniel Winetsky, MD, MS; Jacek Slowikowski, MPH; Jason Zucker, MD; Matthew Scherer, MD; Peter Gordon, MD
    Hepatitis C Virus (HCV) Care Continuum Post-Implementation of Electronic Clinical Decision Support (eCDS) Tool to Increase HCV Screening among Baby Boomers in Large Urban Health System
    Hilary Armstrong, MPH; Marisol Gonzalez-Drigo, RN, MPH; William Trick, MD; Helen Zhang, MS; Lisa Diep, MPH; Oluwatoyin Adeyemi, MD
    Chronic Hepatitis C: Closing the Gap Towards Eradication - Screening Young Adults vs. Baby Boomers
    Michelle Rose, MBA; John Myers, PhD, MSPH,; Scott Duncan, MD; Michael Smith, MD, MSCE; Claudia Espinosa, MD, MSC
    Polymerase Chain Reaction (PCR) for Detection of Vertically-Acquired Hepatitis C Virus (HCV) Infection in Early Infancy
    Jonathan Honegger, MD; Linda Crim, CNP; Charitha Gowda, MD; Pablo J. Sanchez, MD, FIDSA, FPIDS
    Hepatitis C treatment wanted yet not received: barriers to receiving HCV treatment among people who inject drugs
    Shashi Kapadia, MD, MS; Yesenia Aponte-Melendez, MA; Chunki Fong, MS; Benjamin Eckhardt, MD; Laz Davis, .; Bruce R. Schackman, PhD; Kristen M. Marks, MD; Pedro Mateu-Gelabert, PhD
    Demographic Trends and Health Care Utilization Among Children With Hepatitis C Virus Infection
    Brian R. Lee, MPH, PhD; A. Sidney Barritt IV, MD, MSCR; Ravi Jhaveri, MD, FIDSA, FPIDS
    Treatment Uptake for Hepatitis C Virus Infection in the Veterans Affairs Healthcare System in the Era of Directly Acting Antiviral Agents: An ERCHIVES Study
    Adeel Ajwad Butt, Professor of Medicine/Professor of Healthcare Policy and Research; Peng Yan, MS; Vincent Lo Re III, MD, MSCE; Obaid Shaikh, MD
    Wirelessly Observed Therapy with a Digital Medicines Program to Optimize Adherence and Target Interventions for Oral Hepatitis C Treatment
    Maurizio Bonacini, MD; Yoona Kim, PharmD, PhD; Caroline Pitney, PharmD; Lee McKoin, BA; Melody Tran, PharmD, MS; Charles Landis, MD
    Active substance use should not be a contraindication for Hepatitis C treatment in Hepatitis C and Human Immunodeficiency Virus co-infected patients
    Nabil Zeineddine, MD; Dagan Coppock, MD; Zsofia Szep, MD; Tiffany Scott, Research Assistant; Taneesa Franks, Research assistant; Anna Kesaris, Research Assistant; Edgar Chou, MD; Dong Heun Lee, MD
    Impact of Sustained Virologic Response Achieved Through Newer Direct Acting Antivirals in Hepatitis C Infection on Diabetes Mellitus
    Pradeep Kumar Mada, MD; Matthew E Malus, MD; Bing Chen, MD; Sharon Adley, Nurse Rotation Instructor; Gabriel Castano, MD; Maureen Moore, Co-ordinator; Mohammed Alam, MD; John King, MD
  • Hep C and DM .pdf (461.0 kB)
  • Effect of Direct-Acting Antivirals in Hemodialysis Patients with HCV:real-life data
    Nurten Nur Aydin, Assistant doctor; Firdevs Aksoy, Assistant Professor; Ilknur Yavuz, assistant proffessor; Serap Iskender, md; Arzu Altunçekic Yildirim, assistant proffessor; Ilknur Esen Yildiz, assistant proffessor; Iftihar Koksal, Professor
  • Koksal I, HCV, hemodialysis.pdf (472.4 kB)
  • Receipt and Virologic Outcomes of HCV Direct-Acting Antivirals by Alcohol Use and HIV Status
    Emily J. Cartwright, MD; Christopher T. Rentsch, MPH; Denise A. Esserman, PhD; Janet P. Tate, MPH, ScD; David A. Fiellin, MD; Vincent Lo Re III, MD, MSCE; Amy C. Justice, MD, PhD
  • IDSA_DAA_HIVAUD_v2.pdf (229.6 kB)
  • Short-duration of Direct-acting Antivirals in Hepatitis C Virus Infected Cancer Patients
    Jeff Hosry, M.D.; Georgios Angelidakis, MD; Bruno Granwehr, M.D.; Harrys Torres, M.D.
    Low Hepatitis C Virus Reinfection Rates after Sustained Viral Response in HIV co-infected patients in Houston, Texas.
    Lynda Offor, MD; Qianmiao Gao, BS; Lauren Mellor-Crummey, BS; Hongyu Miao, MS, PhD.; Ben Barnett, MD; Karen J. Vigil, MD
    Treatment Outcomes for Hepatitis C Patients from Two Federally Qualified Community Health Centers in South Carolina.
    Akinwale Olatosi, MD; Rishika Motiani, MD; Adelero Adebajo, MD; Ramesh Bharadwaj, MD; Julio Arroyo, MD; Ada Stewart, MD; Bankole Olatosi, PhD
  • IDSA_Poster Presentation..pdf (331.3 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.